KYTHERA BIOPHARMACEUTICALS I - COM (KYTH)

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM
Total 13F shares
21,435,342
Share change
-664,557
Total reported value
$1,606,958,642
Put/Call ratio
107%
Price per share
$74.98
Number of holders
143
Value change
-$51,241,981
Number of buys
85
Number of sells
81

Institutional Holders of KYTHERA BIOPHARMACEUTICALS I - COM (KYTH) as of Q3 2015

As of 30 Sep 2015, KYTHERA BIOPHARMACEUTICALS I - COM (KYTH) was held by 143 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,435,342 shares. The largest 10 holders included JENNISON ASSOCIATES LLC, Palo Alto Investors, LLC, GABELLI FUNDS LLC, CNH PARTNERS LLC, BlackRock Fund Advisors, WATER ISLAND CAPITAL LLC, VANGUARD GROUP INC, Pentwater Capital Management LP, BRIDGER MANAGEMENT, LLC, and Magnetar Financial LLC. This page lists 143 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.